Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
In vitro and in vivo effects of oxidative damage to deoxyguanosine
CC90001 currently under clinical trials for the Treatment of Idiopathic Pulmonary Fibrosis
09 to 60 μM (0
CCCC(CCC)C(O)=O |^1:0|
PI-1840 - CAS# 1401223-22-0 ogest In vitro and in vivoPI 1840 is a is a novel rapidly reversible proteasome inhibitor with antitumor activity. It shows selective inhibitor for chymotrypsin like (CT L) over trypsin like and peptidylglutamyl peptide hydrolyzing activities of the proteasome. Product information CAS Number: 1401223 22 0 Molecular Weight: 394. 47 Formula: C22H26N4O3 Chemical Name: N (propan 2 yl) 2 (4 propylphenoxy) N {[3 (pyridin 3 yl) 1,2,4 oxadiazol 5 yl]methyl}acetamide Smiles:
US$ 332.46
US$ 496.31
US$ 285.44
US$ 140.00
US$ 25.00
US$ 314.75
US$ 433.55